Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1689862

registered interest
date	19/02/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people aged under 18 have been prescribed medicinal cannabis as of 19 February 2024.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	14583
answer	answer is ministerial correction date of answer 27/02/2024 answer text <p>The Department does not hold details relating to the age of people prescribed medicinal cannabis.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 27/02/2024 11:18:22 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4131 label Biography information for Jim Shannon

1689392

registered interest
date	16/02/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans her Department has to make medicinal cannabis more accessible to those who need it.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Paula Barker
uin	14291
answer	answer is ministerial correction date of answer 21/02/2024 answer text <p>Licensed cannabis-based medicines are routinely available on the National Health Service. However, clinical guidelines from the National Institute for Health and Care Excellence (NICE) demonstrate a clear need for more evidence to support routine prescribing and funding decisions for unlicensed cannabis-based medicines.</p><p> </p><p>The Government continues to call on manufacturers to invest in research and clinical trials to prove if their products are safe and effective and offers scientific and research advice from the Medicines and Healthcare products Regulatory Agency and the NICE.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 21/02/2024 09:43:53 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4828 label Biography information for Paula Barker

1687065

registered interest
date	02/02/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress she has made with (a) regulatory, (b) research and (c) NHS partners on establishing clinical trials to test the (i) safety and (ii) efficacy of medical cannabis products.
tabling member constituency	Somerton and Frome
tabling member printed	Sarah Dyke
uin	12872
answer	answer is ministerial correction date of answer 09/02/2024 answer text <p>The Department, via the National Institute for Health and Care Research (NIHR), is developing a programme of two randomised controlled trials to test the safety and efficacy of medicinal cannabis products to treat epilepsy in adults and children. The trials will start as soon as possible, and the results will be published once the trials have completed and the findings peer reviewed.</p><p> </p><p>Furthermore, the Government continues to encourage manufacturers to invest in research and has highlighted that public funding is available for high quality applications. The Medicines and Healthcare products Regulatory Agency and the NIHR can provide applicants with scientific and research advice.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 09/02/2024 10:47:53 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4995 label Biography information for Sarah Dyke